RAPT Therapeutics, Inc. (NASDAQ: RAPT) reported Q3 EPS of ($0.47), $0.09 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on RAPT Therapeutics, Inc. (RAPT) click here.